Sex differences in smoking cessation outcomes of a tailored program for individuals with substance use disorders and mental illness.

Tobacco use is highly prevalent among individuals with a history of substance use disorders (SUD) and/or mental illness (MI)…

Smoking Cessation among Persons with Co-occurring Substance Use Disorder and Mental Illness.

Aims: A history of either a substance use disorder (SUD) or psychiatric disorder (PD) is associated with tobacco use…

Smoking cessation outcomes among individuals with substance use and/or psychiatric disorders.

Individuals with substance use and psychiatric disorders have a high prevalence of tobacco use disorders and are disproportionately affected by tobacco-related morbidity and mortality…

Factors associated with staff engagement in patients’ tobacco treatment in a state psychiatric facility.

Persons with mental illnesses (MI) who use tobacco are likely to experience poorer physical health and worsened psychiatric symptomology as compared to their non–tobacco-using counterparts…

A cross-sectional analysis of factors associated with the intention to engage in tobacco treatment among inpatients in a state psychiatric hospital.

WHAT IS KNOWN ON THE SUBJECT?: People admitted to psychiatric facilities have high rates of tobacco use and hospitalizations present an opportunity for patients to have conversations…

Which types of tobacco treatment interventions work for people with schizophrenia? Provider and mental health consumer perspectives.

People with schizophrenia and other psychotic disorders (PWS) consume tobacco at high rates, resulting in disproportionate tobacco-related morbidity and mortality…

Assessing opinions and barriers to providing evidence-based tobacco treatment among health care providers within an in-patient psychiatric facility

Tobacco-related morbidity and mortality is high among people with mental illnesses (PMI), yet tobacco treatment (TT) is often not provided by mental health care providers (MHPs)…